197 related articles for article (PubMed ID: 28866309)
1. Management around invasive procedures in mastocytosis: An update.
Hermans MAW; Arends NJT; Gerth van Wijk R; van Hagen PM; Kluin-Nelemans HC; Oude Elberink HNG; Pasmans SGMA; van Daele PLA
Ann Allergy Asthma Immunol; 2017 Oct; 119(4):304-309. PubMed ID: 28866309
[TBL] [Abstract][Full Text] [Related]
2. Drug allergy in mastocytosis.
Bonadonna P; Lombardo C
Immunol Allergy Clin North Am; 2014 May; 34(2):397-405. PubMed ID: 24745682
[TBL] [Abstract][Full Text] [Related]
3. Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Gotlib J; Gerds AT; Bose P; Castells MC; Deininger MW; Gojo I; Gundabolu K; Hobbs G; Jamieson C; McMahon B; Mohan SR; Oehler V; Oh S; Padron E; Pancari P; Papadantonakis N; Pardanani A; Podoltsev N; Rampal R; Ranheim E; Rein L; Snyder DS; Stein BL; Talpaz M; Thota S; Wadleigh M; Walsh K; Bergman MA; Sundar H
J Natl Compr Canc Netw; 2018 Dec; 16(12):1500-1537. PubMed ID: 30545997
[TBL] [Abstract][Full Text] [Related]
4. Mast Cell Disorders In Drug Hypersensitivity.
Bonadonna P; Bonifacio M; Zanotti R
Curr Pharm Des; 2016; 22(45):6862-6869. PubMed ID: 27779084
[TBL] [Abstract][Full Text] [Related]
5. [IgE mediated anaphylaxis in a patient with systemic mastocytosis].
Escande H; Bennani I; Bulai Livideanu C; Uthurriague C; Paul C; Nougué J
Ann Dermatol Venereol; 2013 Oct; 140(10):641-4. PubMed ID: 24090896
[TBL] [Abstract][Full Text] [Related]
6. Management of Anesthesia in Adult and Pediatric Mastocytosis: A Study of the Spanish Network on Mastocytosis (REMA) Based on 726 Anesthetic Procedures.
Matito A; Morgado JM; Sánchez-López P; Álvarez-Twose I; Sánchez-Muñoz L; Orfao A; Escribano L
Int Arch Allergy Immunol; 2015; 167(1):47-56. PubMed ID: 26160029
[TBL] [Abstract][Full Text] [Related]
7. Critical care management of systemic mastocytosis: when every wasp is a killer bee.
van der Weide HY; van Westerloo DJ; van den Bergh WM
Crit Care; 2015 Jun; 19(1):238. PubMed ID: 26036415
[TBL] [Abstract][Full Text] [Related]
8. Current approaches to the diagnosis and treatment of systemic mastocytosis.
Bains SN; Hsieh FH
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):1-10; quiz 10-2, 41. PubMed ID: 20143640
[TBL] [Abstract][Full Text] [Related]
9. Anaphylaxis with clonal mast cells in normal looking skin - a new entity?
Bretterklieber A; Beham-Schmid C; Sturm GJ; Berghold A; Brezinschek R; Aberer W; Aberer E
Allergy; 2015 Jul; 70(7):864-72. PubMed ID: 25899109
[TBL] [Abstract][Full Text] [Related]
10. [Sudden death in the presence of systemic mastocytosis and urticaria pigmentosa].
Wehner F; Wehner HD; Fritz P; Benz D; Schulz MM
Arch Kriminol; 2008; 222(5-6):187-94. PubMed ID: 19216369
[TBL] [Abstract][Full Text] [Related]
11. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
12. [Mastocytosis in childhood].
Renke J; Lange M
Przegl Lek; 2006; 63(7):551-3. PubMed ID: 17203807
[TBL] [Abstract][Full Text] [Related]
13. Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis.
Zanotti R; Bonadonna P; Bonifacio M; Artuso A; Schena D; Rossini M; Perbellini O; Colarossi S; Chilosi M; Pizzolo G
Haematologica; 2011 Mar; 96(3):482-4. PubMed ID: 21193416
[No Abstract] [Full Text] [Related]
14. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.
Gülen T; Hägglund H; Dahlén B; Nilsson G
Clin Exp Allergy; 2014 Jan; 44(1):121-9. PubMed ID: 24164252
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic anaphylaxis and systemic mastocytosis.
Francischetti IMB; Maric I
Int J Hematol; 2019 Dec; 110(6):643-644. PubMed ID: 31606842
[No Abstract] [Full Text] [Related]
16. The presence of mast cell clonality in patients with unexplained anaphylaxis.
Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G
Clin Exp Allergy; 2014 Sep; 44(9):1179-87. PubMed ID: 25039926
[TBL] [Abstract][Full Text] [Related]
17. Indolent systemic mastocytosis: a case and review of the current available treatment options.
Lee Y; Wood P; Soyer HP
Dermatol Online J; 2013 Jun; 19(6):18562. PubMed ID: 24011312
[TBL] [Abstract][Full Text] [Related]
18. Safety of a 2-day ultrarush immunotherapy in vespid allergic patients: Focus on elevated serum tryptase.
Bilò MB; Corsi A; Agolini S; Tontini C; Antonicelli L
Ann Allergy Asthma Immunol; 2018 Jul; 121(1):130-132. PubMed ID: 29577980
[No Abstract] [Full Text] [Related]
19. Systemic mastocytosis--a systematic review.
Andersen CL; Kristensen TK; Severinsen MT; Møller MB; Vestergaard H; Bergmann OJ; Hasselbalch HC; Bjerrum OW
Dan Med J; 2012 Mar; 59(3):A4397. PubMed ID: 22381091
[TBL] [Abstract][Full Text] [Related]
20. [New views on systemic mastocytosis].
Pluta A; Gutkowski K
Pol Merkur Lekarski; 2003 Feb; 14(80):159-62. PubMed ID: 12728681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
